Production of interleukin-1-receptor antagonist during experimental endotoxaemia

E. V. Granowitz, D. D. Poutsiaka, J. G. Cannon, S. M. Wolff, C. A. Dinarello, A. A. Santos, D. W. Wilmore

Research output: Contribution to journalArticle

250 Scopus citations

Abstract

Interleukin-1 (IL-1) has been implicated in the pathogenesis of sepsis. IL-1-receptor antagonist (IL-1ra) is a naturally occurring inhibitor of IL-1 activity that competes with IL-1 for occupancy of cell-surface receptors but possesses no agonist activity. We induced endotoxaemia in 9 healthy human volunteers by injection of Escherichia coliendotoxin, and measured plasma concentrations of IL-1 and IL-1ra by radioimmunoassay during the next 24 h. Peak plasma concentrations of IL-1ra were about a hundred-fold greater than those of IL-1β. No IL-1 or IL-1ra were detectable in the plasma of 4 volunteers injected with saline. Our results suggest that the predominant natural response to endotoxin in man is the production of antagonist rather than agonist.

Original languageEnglish (US)
Pages (from-to)1423-1424
Number of pages2
JournalThe Lancet
Volume338
Issue number8780
DOIs
Publication statusPublished - Dec 7 1991

    Fingerprint

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Granowitz, E. V., Poutsiaka, D. D., Cannon, J. G., Wolff, S. M., Dinarello, C. A., Santos, A. A., & Wilmore, D. W. (1991). Production of interleukin-1-receptor antagonist during experimental endotoxaemia. The Lancet, 338(8780), 1423-1424. https://doi.org/10.1016/0140-6736(91)92725-H